Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-20,214
Closed -$360K 200
2023
Q1
$360K Hold
20,214
0.04% 161
2022
Q4
$396K Hold
20,214
0.05% 152
2022
Q3
$386K Buy
20,214
+4,958
+32% +$100K 0.07% 143
2022
Q2
$273K Hold
15,256
0.07% 160
2022
Q1
$441K Hold
15,256
0.11% 116
2021
Q4
$422K Hold
15,256
0.1% 128
2021
Q3
$414K Hold
15,256
0.1% 121
2021
Q2
$429K Hold
15,256
0.08% 120
2021
Q1
$336K Hold
15,256
0.06% 156
2020
Q4
$285K Buy
15,256
+3,069
+25% +$55.2K 0.06% 153
2020
Q3
$188K Hold
12,187
0.05% 136
2020
Q2
$186K Hold
12,187
0.06% 130
2020
Q1
$156K Hold
12,187
0.17% 114
2019
Q4
$293K Hold
12,187
0.21% 107
2019
Q3
$257K Buy
+12,187
New +$252K 0.2% 111

Other funds holding TBI

Unison Advisors's TBI Position: Q2 2023 in Review

Unison Advisors sold out of Trueblue (TBI) in Q2 2023, closing a stake of 20,214 shares — an estimated $360K sold.

Unison Advisors first reported a position in TBI in Q3 2019 and held it in 15 quarters. The position peaked at $441K in Q1 2022. 151 funds tracked by Wall St. Rank hold TBI as of Q2 2023.

  • Unison Advisors reported no remaining Trueblue position as of Q2 2023 after selling out during the quarter.
  • Unison Advisors sold 20,214 Trueblue shares in Q2 2023, an estimated $360K.
  • Unison Advisors first reported a position in Trueblue in Q3 2019 and held it in 15 quarters.
  • Unison Advisors's Trueblue position peaked at $441K in Q1 2022.
  • 151 funds tracked by Wall St. Rank held Trueblue as of Q2 2023.

Based on Unison Advisors's 13F filing for Q2 2023, filed 28 Jul 2023.